Homeowners Choice (HCI) 30.81 $HCI HCI Group Appoints

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Homeowners Choice (HCI) 30.81 $HCI

HCI Group Appoints Former E.W. Blanch CEO, Ted Blanch, as President of TypTap
GlobeNewswire - Mon Jun 06, 7:00AM CDT
HCI Group, Inc. (NYSE:HCI), a holding company primarily engaged in homeowners insurance, with additional operations in reinsurance, real estate and information technology, has appointed insurance industry veteran Ted Blanch as president of TypTap Insurance Company, HCI's new online insurance company.
HCI: 30.81 (+0.05)

HCI Group Reports First Quarter 2016 Results
GlobeNewswire - Tue May 03, 3:15PM CDT
HCI Group, Inc. (NYSE:HCI), a holding company primarily engaged in homeowners insurance, with additional operations in reinsurance, real estate and information technology, reported results for the quarter ended March 31, 2016.
HCI: 30.81 (+0.05)

Investor Calendar Invites You to the HCI Group First Quarter 2016 Earnings Conference Call and Webcast Live on Tuesday May 3, 2016
ACCESSWIRE - Mon May 02, 3:11PM CDT
TAMPA, FL / ACCESSWIRE / May 2, 2016 / HCI Group, Inc. (NYSE: HCI) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Tuesday, May 3, 2016 at 4:45 PM Eastern Time.
HCI: 30.81 (+0.05)

HCI Group Declares Q2 2016 Regular Quarterly Cash Dividend
GlobeNewswire - Tue Apr 19, 7:30AM CDT
The board of directors of HCI Group, Inc. (NYSE:HCI), a holding company primarily engaged in homeowners insurance, with additional operations in reinsurance, real estate and information technology, has declared a regular quarterly cash dividend in the amount of 30 cents per common share for the second quarter of 2016. The dividend will be paid June 17, 2016 to shareholders of record on the close of business May 20, 2016.
HCI: 30.81 (+0.05)

HCI Group to Participate at the Piper Jaffray Financial Institutions Conference on May 5-6, 2016
GlobeNewswire - Mon Apr 18, 3:11PM CDT
HCI Group, Inc. (NYSE:HCI), a holding company primarily engaged in homeowners insurance, with additional operations in reinsurance, real estate and information technology, has been invited to participate at the Piper Jaffray Financial Institutions Conference being held May 5-6, 2016 at the Four Seasons Resort Orlando.
HCI: 30.81 (+0.05)

HCI Group Sets First Quarter 2016 Earnings Call for Tuesday, May 3, 2016 at 4:45 p.m. ET
GlobeNewswire - Thu Apr 14, 3:05PM CDT
HCI Group, Inc. (NYSE:HCI), a holding company primarily engaged in homeowners insurance, reinsurance, real estate and information technology, plans to hold a conference call on Tuesday, May 3, 2016 at 4:45 p.m. Eastern time to discuss results for the first quarter ended March 31, 2016. Financial results will be issued in a press release after the close of the market on the same day.
HCI: 30.81 (+0.05)

HCI Group Launches TypTap.com
GlobeNewswire - Wed Mar 09, 7:30AM CST
HCI Group, Inc. (NYSE:HCI), predominantly engaged in homeowners insurance, reinsurance, real estate and information technology, has launched TypTap.com, an online platform for quoting and binding flood insurance policies in Florida.
HCI: 30.81 (+0.05)

HCI Group Q4 Earnings Hit by High Expenses, Revenues Fall
Zacks Equity Research - Zacks Investment Research - Fri Mar 04, 9:50AM CST
HCI Group Inc. (HCI) reported operating earnings per share of $1.05 for the fourth quarter of 2015. The bottom line missed the Zacks Consensus Estimate of $1.19 by nearly 12% and declined 19% year over year.
RLI: 67.12 (-0.19), HCI: 30.81 (+0.05), AFL: 68.95 (-0.75), TRV: 113.81 (-0.41)

HCI Group posts 4Q profit
Automated Insights - Thu Mar 03, 4:10PM CST
TAMPA, Fla. (AP) _ HCI Group Inc. (HCI) on Thursday reported fourth-quarter profit of $11.1 million.
HCI: 30.81 (+0.05)

HCI Group Reports Fourth Quarter and Full Year 2015 Results
GlobeNewswire - Thu Mar 03, 3:15PM CST
HCI Group, Inc. (NYSE:HCI), a holding company primarily engaged in homeowners insurance, as well as reinsurance, real estate and information technology, reported results for the fourth quarter and full year ended December 31, 2015.
HCI: 30.81 (+0.05)

Investor Calendar Invites You to the HCI Group Fourth Quarter and Fiscal Year 2015 Earnings Conference Call and Webcast Live on Thursday March 3, 2016
ACCESSWIRE - Wed Mar 02, 3:11PM CST
TAMPA, FL / ACCESSWIRE / March 2, 2016 / HCI Group, Inc. (NYSE: HCI) will host a conference call and live webcast to discuss the results of the fourth quarter and fiscal year 2015, to be held Thursday, March 3, 2016 at 4:45 PM Eastern Time.
HCI: 30.81 (+0.05)

Technical Data on Property & Casualty Insurance Stocks -- WMIH Corp., United Insurance Holdings, HCI Group, and State National Co.
ACCESSWIRE - Wed Dec 23, 7:03AM CST
NEW YORK, NY / ACCESSWIRE / December 23, 2015 / Park Lane Advisor has initiated coverage on the following equities: WMIH Corporation (NASDAQ: WMIH), United Insurance Holdings Corporation (NASDAQ: UIHC), HCI Group Inc. (NYSE: HCI), and State National Companies Inc. (NASDAQ: SNC). Free research report on WMIH Corp. can be accessed at http://www.parklaneadvisor.com/ On Tuesday, December 22, 2015, the NASDAQ Composite ended at 5,001.11, up 0.65%, the Dow Jones Industrial Average advanced 0.96%, to finish the day at 17,417.27, and the S&P 500 closed at 2,038.97, up 0.88%. The gains were broad based as all the sectors ended the session in positive. Register for your complimentary reports at the links given below.
UIHC: 17.59 (-0.16), HCI: 30.81 (+0.05), WMIH: 2.34 (+0.01), SNC: 10.70 (-0.26)

HCI Group Authorizes $20 Million Stock Repurchase Program
GlobeNewswire - Tue Dec 15, 4:15PM CST
The board of directors of HCI Group, Inc. (NYSE:HCI) has authorized a plan to repurchase up to $20 million of the company's common shares until December 31, 2016, subject to market conditions.
HCI: 30.81 (+0.05)

5 Value Picks in the Finance Sector Pre-Rate Hike
Zacks Equity Research - Zacks Investment Research - Tue Nov 10, 1:40PM CST
Given the possibility of a rate hike, it is wise to bet on the safety of value stocks, i.e. to identify the stocks that are truly trading at a discount.
AHL: 47.33 (-0.44), MGRC: 30.17 (-0.08), EIG: 29.73 (-0.02), HCI: 30.81 (+0.05), AI: 13.70 (-0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 42

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 309

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 84

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Farmmi Receives Extension to Comply with NASDAQ Requirements

Updated Category News Views 64

Farmmi Secures NASDAQ Compliance Extension Farmmi, Inc. (NASDAQ: FAMI), a supplier of agricultural products, has been granted a 180-day extension by NASDAQ to meet its crucial minimum bid price requirement. This extension allows the company until the spring of 2025 to elevate its ordinary share bid price to at least $1.00 for at least ten consecutive business days. The...

Continue Reading
The Neurotechnology Surge: $57B Market by 2034

Updated Category News Views 16

Neurotechnology: The Rising Giant Elbows on the table, let's chew the fat about neurotechnology. The market, dizzyingly projected to soar past USD 57 billion by 2034, is on an explosive trajectory. Folk wiser than us predict an annual growth rate hanging around 14%. This ain't just whispers in coffee shops; it's cold, hard data from DelveInsight’s Market Insights...

Continue Reading
Reviva Pharmaceuticals' New Phase 3 Study for Schizophrenia Drug

Updated Category News Views 99

Reviva Pharmaceuticals' Regulatory Update Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) has recently provided an update regarding their journey with brilaroxazine, a novel drug aimed at treating schizophrenia. This news comes after a pre-New Drug Application meeting with the U.S. Food and Drug Administration (FDA). About Brilaroxazine Brilaroxazine is an innovative...

Continue Reading
Lowe's Reports Strong Earnings Amid Strategic Acquisitions

Updated Category News Views 117

Strong Q2 Earnings Surprise Lowe’s Companies Inc (NYSE: LOW) experienced better-than-expected second quarter earnings, bringing a burst of optimism for investors. The home improvement giant saw its stock increase by approximately 2% shortly after announcing its Q2 financial results. Having recorded solid performance through the quarter, Lowe’s exceeded analysts'...

Continue Reading
Invideo and Kling AI Unite for Game-Changing Visuals

Updated Category News Views 153

Invideo and Kling AI Collaborate to Redefine Video Editing Invideo has recently partnered with Kling AI to introduce an exciting tool known as VFX House. This innovative feature empowers creators with studio-level control for their video projects, offering enhanced capabilities for both marketing and editorial work. Unlocking New Possibilities with VFX House The...

Continue Reading